We are live on ! Find out more
FLAM

First Light Asset Management Portfolio holdings

AUM $1.12B
1-Year Est. Return 114.45%
This Fund
S&P 500
This Quarter Est. Return
+19.44%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$1.11B
AUM Growth
+$33.3M
Cap. Flow
-$6.36M
Cap. Flow %
-0.57%
Top 10 Hldgs %
54.13%
Holding
78
New
4
Increased
24
Reduced
16
Closed
4

Top Buys

Rank Stock Value
1
OFIX icon
Orthofix Medical
OFIX
+$51.9M
2
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
+$15.1M
3
FNA
Paragon 28, Inc.
FNA
+$14.3M
4
OPRX icon
OptimizeRx
OPRX
+$10.9M
5
PLRX icon
Pliant Therapeutics
PLRX
+$10.5M

Top Sells

Rank Stock Value
1
SPNE
SeaSpine Holdings Corporation Common Stock
SPNE
+$57.4M
2
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
+$27.9M
3
KRYS icon
Krystal Biotech
KRYS
+$21.8M
4
MODN
MODEL N, INC.
MODN
+$15.6M
5
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$15.6M

Sector Composition

Rank Sector Weight
1 Healthcare 94.41%
2 Communication Services 5.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RETA
1
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$144M 12.99%
1,586,928
-475,525
-23% -$27.9M
PRTA icon
2
Prothena Corp
PRTA
$425M
$73.2M 6.6%
1,511,168
-24,431
-2% -$1.29M
MODN
3
DELISTED
MODEL N, INC.
MODN
$62M 5.59%
1,853,673
-428,948
-19% -$15.6M
ATRC icon
4
AtriCure
ATRC
$1.92B
$60.5M 5.45%
1,459,057
+6,543
+0.5% +$272K
NEO icon
5
NeoGenomics
NEO
$1.96B
$47M 4.23%
2,698,958
+16,787
+0.6% +$239K
ATEC icon
6
Alphatec Holdings
ATEC
$1.46B
$45.9M 4.14%
2,944,125
+17,952
+0.6% +$254K
OFIX icon
7
Orthofix Medical
OFIX
$477M
$44.4M 4%
+2,650,971
New +$51.9M
KRTX
8
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$44.3M 3.99%
243,675
+79,060
+48% +$15.1M
SIBN icon
9
SI-BONE Inc
SIBN
$788M
$41.6M 3.74%
2,114,212
+8,759
+0.4% +$156K
PLRX icon
10
Pliant Therapeutics
PLRX
$64.4M
$37.9M 3.41%
1,425,354
+367,473
+35% +$10.5M
FNA
11
DELISTED
Paragon 28, Inc.
FNA
$34.8M 3.13%
2,037,939
+801,677
+65% +$14.3M
PHLT
12
DELISTED
Performant Healthcare Inc
PHLT
$27.9M 2.51%
8,210,699
+823,419
+11% +$2.69M
HALO icon
13
Halozyme
HALO
$9.79B
$26.3M 2.37%
688,206
-234,913
-25% -$11M
KRMD icon
14
KORU Medical Systems
KRMD
$189M
$26.1M 2.35%
6,191,317
-146,765
-2% -$577K
CRNX icon
15
Crinetics Pharmaceuticals
CRNX
$8.84B
$26M 2.34%
1,619,125
+289,812
+22% +$5.36M
TMDX icon
16
Transmedics
TMDX
$2.64B
$25.6M 2.3%
337,912
+72,815
+27% +$5.04M
KROS icon
17
Keros Therapeutics
KROS
$199M
$25.4M 2.28%
593,964
+1,552
+0.3% +$78.4K
TNDM icon
18
Tandem Diabetes Care
TNDM
$1.34B
$23.9M 2.15%
589,185
+3,035
+0.5% +$126K
HCAT icon
19
Health Catalyst
HCAT
$154M
$23.1M 2.08%
1,980,317
+818,322
+70% +$10.4M
BLU
20
DELISTED
BELLUS Health Inc.
BLU
$21.7M 1.96%
3,020,393
+663,443
+28% +$5.15M
OMCL icon
21
Omnicell
OMCL
$1.61B
$19.6M 1.76%
333,509
-10,642
-3% -$587K
AXGN icon
22
Axogen
AXGN
$2.27B
$18.3M 1.65%
1,941,096
-430,752
-18% -$3.94M
AXNX
23
DELISTED
Axonics, Inc. Common Stock
AXNX
$16.9M 1.52%
309,240
-1,209
-0.4% -$70.6K
KRYS icon
24
Krystal Biotech
KRYS
$10.1B
$15.7M 1.41%
195,980
-277,711
-59% -$21.8M
BCYC
25
Bicycle Therapeutics
BCYC
$269M
$14.9M 1.34%
699,328
+2,896
+0.4% +$72.6K
1
2 3 4

Similar funds

AIM
Advyzon Investment Management Lisle, Illinois $1.12B AUM 22.08% 1-Year Est. Return
MTCM
Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return
CNC
Canandaigua National Corp Canandaigua, New York $1.12B AUM
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
RIM
Rockbridge Investment Management Syracuse, New York $1.11B AUM 13.62% 1-Year Est. Return
CT
Caldwell Trust Venice, Florida $1.12B AUM 21.31% 1-Year Est. Return
SL
Salomon & Ludwin Richmond, Virginia $1.12B AUM 14.38% 1-Year Est. Return
HH
Hilltop Holdings Dallas, Texas $1.11B AUM 24.7% 1-Year Est. Return

First Light Asset Management's Q1 2023 Portfolio in Review

As of Q1 2023, First Light Asset Management held 78 positions worth $1.11B, up 3.1% from $1.08B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

First Light Asset Management's Q1 2023 filing shows 4 new, 24 increased, 16 reduced and 4 closed positions. Its largest new stake was Orthofix Medical: 2,650,971 shares worth $44.4M. The largest sale was SeaSpine Holdings Corporation Common Stock, an estimated $57.4M.

By sector, the portfolio is most concentrated in Healthcare at 94% of assets, up from 86% a quarter earlier, followed by Communication Services.

  • First Light Asset Management's largest Q1 2023 buy was Orthofix Medical: 2,650,971 shares worth $44.4M.
  • First Light Asset Management added most to Karuna Therapeutics, Inc. Common Stock in Q1 2023, an estimated $15.1M increase.
  • First Light Asset Management's biggest Q1 2023 reduction was Reata Pharmaceuticals, Inc. Class A Common Stock, cutting an estimated $27.9M.
  • First Light Asset Management fully exited SeaSpine Holdings Corporation Common Stock in Q1 2023, selling an estimated $57.4M.
  • First Light Asset Management's ten largest holdings make up 54% of its $1.11B portfolio in Q1 2023.
  • First Light Asset Management opened 4 new positions and closed 4 in Q1 2023.
  • First Light Asset Management's portfolio value rose 3.1% quarter-over-quarter to $1.11B.

Based on First Light Asset Management's 13F filing for Q1 2023, filed 15 May 2023.